Status and phase
Conditions
Treatments
About
This research study is studying an investigational drug called EOC237 in Patients With Advanced Solid Tumor.
Full description
Part 1 Dose Escalation: an open, single/multiple dose, multi-center phase I study to evaluate the safety, tolerability and pharmacokinetics of EOC237 in Patients With Advanced Solid Tumor.
Part 2 Food influence research: to assess the effect of food on the pharmacokinetics of EOC237, by investigating the bioavailability following single dose administration under fed and fasted conditions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
48 participants in 3 patient groups
Loading...
Central trial contact
Binghe Xu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal